Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia

Kaitlyn Hastings, Clara Marquina, Jedidiah Morton, Dina Abushanab, Danielle Berkovic, Stella Talic, Ella Zomer, Danny Liew and Zanfina Ademi ()
Additional contact information
Kaitlyn Hastings: Monash University
Clara Marquina: Monash University
Jedidiah Morton: Monash University
Dina Abushanab: Monash University
Stella Talic: Monash University
Ella Zomer: Monash University
Danny Liew: Monash University
Zanfina Ademi: Monash University

PharmacoEconomics, 2022, vol. 40, issue 4, No 5, 449-460

Abstract: Abstract Background Socioeconomic status has an important effect on cardiovascular disease (CVD). Data on the economic implications of CVD by socioeconomic status are needed to inform healthcare planning. Objectives The aim of this study was to project new-onset CVD and related health economic outcomes in Australia by socioeconomic status from 2021 to 2030. Methods A dynamic population model was built to project annual new-onset CVD by socioeconomic quintile in Australians aged 40–79 years from 2021 to 2030. Cardiovascular risk was estimated using the Pooled Cohort Equation (PCE) from Australian-specific data, stratified for each socioeconomic quintile. The model projected years of life lived, quality- adjusted life-years (QALYs), acute healthcare medical costs, and productivity losses due to new-onset CVD. All outcomes were discounted by 5% annually. Results PCE estimates showed that 8.4% of people in the most disadvantaged quintile were at high risk of CVD, compared with 3.7% in the least disadvantaged quintile (p

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-021-01127-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-021-01127-1

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-021-01127-1

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().